FrancophonIA/ELRC3.0 huggingface dataset:
English: Over 800 patients with moderate to severe symptoms of BPH (International Prostate Symptom Score, IPSS, baseline value ≥ 13) received silodosin 8 mg once daily in two Phase III placebo-controlled clinical studies conducted in the United States and in one placebo- and active-controlled clinical study conducted in Europe.
Danish: Over 800 patienter med moderate til svære symptomer på BPH (International Prostate Symptom Score, IPSS, baseline-værdi ≥ 13) fik silodosin 8 mg én gang dagligt i to placebo-kontrollerede kliniske fase III-studier udført i USA, og i et placebo-kontrolleret og aktivt kontrolleret klinisk studie udført i Europa.
English: This effect disappears after discontinuation of Silodyx.
Danish: Denne virkning forsvinder, når behandlingen med Silodyx ophører.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Silodyx in all subsets of the paediatric population in BPH (see section 4.2 for information on paediatric use).
Danish: Det Europæiske Lægemiddelagentur har dispenseret fra kravet om at fremlægge resultaterne af studier med med referencelægemidlet, som indeholder Silodyx i alle undergrupper af den pædiatriske population med BPH (se pkt.
English: Elderly No dose adjustment is required in the elderly (see section 5.2).
Danish: Ældre Det er ikke nødvendigt at justere dosis hos ældre (se pkt.
English: Silodyx is used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate (prostatic hyperplasia), such as:
Danish: Silodyx anvendes hos voksne mænd for at behandle urinsvejssymptomer forbundet med en godartet forstørrelse af blærehalskirtlen (prostatahyperplasi), såsom:
English: There is no relevant use of Silodyx in the paediatric population for the indication of benign prostatic hyperplasia (BPH).
Danish: Det er ikke relevant at anvende Silodyx hos den pædiatriske population til indikationen godartet prostatahyperplasi (BPH).
English: In a Phase II dose-finding, double-blind, placebo-controlled clinical study with silodosin 4 or 8 mg once daily, a greater improvement in American Urologic Association (AUA) symptom index score was observed with silodosin 8 mg (-6.8 ± 5.8, n = 90; p = 0.0018) and silodosin 4 mg (-5.7 ± 5.5, n = 88; p = 0.0355) as compared to placebo (-4.0 ± 5.5, n = 83).
Danish: I et dobbelt-blindet, placebo-kontrolleret klinisk dose-finding, fase II-studie med silodosin 4 eller 8 mg én gang dagligt, blev der observeret en større forbedring i index score af symptomer i henhold til American Urologic Association (AUA) med silodosin 8 mg (-6,8 ± 5,8; n = 90; p = 0,0018) og silodosin 4 mg (-5,7 ± 5,5; n = 88; p = 0,0355) sammenlignet med placebo (-4,0 ± 5,5; n = 83).
English: Intraoperative Floppy Iris Syndrome (IFIS) IFIS has been reported during cataract surgery (see section 4.4).
Danish: Intraoperativt Floppy-iris-syndrom (IFIS) IFIS er blevet indberettet under operation for grå stær (se pkt.
English: • medicines used for treating problems in getting or keeping an erection (such as sildenafil or tadalafil), since the concomitant use with Silodyx might lead to a slight decrease in blood pressure.
Danish: • medicin til behandling af problemer med at få og opretholde en erektion (såsom sildenafil eller tadalafil), da samtidig anvendelse med Silodyx kan føre til et let blodtryksfald.
English: • antifungal medicines (such as ketoconazole or itraconazole), medicines used for HIV-AIDS (such as ritonavir) or medicines used after transplants to prevent organ rejection (such as cyclosporin) because these medicines can increase the blood concentration of Silodyx.
Danish: • medicin mod svampeinfektion (såsom ketoconazol eller itraconazol), medicin der anvendes mod HIV-infektion/AIDS (såsom ritonavir) eller medicin der anvendes efter transplantationer for at forhindre organafstødning (såsom ciclosporin), da disse former for medicin kan forhøje koncentrationen af Silodyx i blodet.
English: ZAMBON nv-sa Tél/Tel: + 32 2 777 02 00
Danish: Luxembourg/Luxemburg ZAMBON nv-sa Tél/Tel: + 32 2 777 02 00
English: Silodyx does not treat prostate cancer.
Danish: Silodyx kan ikke anvendes til at behandle prostatakræft.
English: Silodyx is not intended for use by women.
Danish: Silodyx er kun beregnet til brug hos mænd.
English: In healthy male subjects of the target age range (n = 16, mean age 55 ± 8 years) after once-a-day oral administration of 8 mg immediately after breakfast for 7 days, the following pharmacokinetic parameters were obtained: Cmax 87 ± 51 ng/mL (sd), tmax 2.5 hours (range 1.0-3.0), AUC 433 ± 286 ng • h/mL.
Danish: Hos raske mandlige frivillige blev de følgende farmakokinetiske parametre opnået inden for målintervallet for alder (n = 16, gennemsnitlig alder 55 ± 8 år) efter oral administration én gang dagligt på 8 mg straks efter morgenmaden i 7 dage: Cmax 87 51 ng/ml (SD), tmax 2,5 timer (interval 1,0-3,0), AUC 433 ± 286 ng • h/ml.
English: Plasma level monitoring in a Phase III clinical study showed that levels of total silodosin after 4 weeks of treatment did not change in patients with mild impairment (n = 70), compared to patients with normal renal function (n = 155), while the levels were doubled on average in patients with moderate impairment (n = 7).
Danish: Overvågning af plasmaniveauerne i et klinisk fase III-studie viste, at niveauerne af total silodosin efter 4 ugers behandling ikke ændrede sig hos patienter med let nedsat nyrefunktion (n = 70), sammenlignet med patienter med normal nyrefunktion (n = 155), mens niveauerne i gennemsnit var dobbelt så store hos patienter med moderat nedsat nyrefunktion (n = 7).
English: Concomitant use with potent CYP3A4 inhibitors (such as ketoconazole, itraconazole, ritonavir or cyclosporine) is not recommended.
Danish: Potente CYP3A4-hæmmere (såsom ketoconazol, itraconazol, ritonavir eller ciclosporin) bør ikke anvendes samtidig med Silodyx.
English: Capsule content Starch, pregelatinised (maize) Mannitol (E421) Magnesium stearate Sodium laurilsulfate
Danish: Stivelse, pregelatineret (majs) Mannitol (E421) Magnesiumstearat Natriumlaurilsulfat
English: If you forget to take Silodyx
Danish: Hvis De har glemt at tage Silodyx
English: The treatment with Silodyx may lead to an abnormal ejaculation (decrease in the amount of semen released during sex) that may temporarily affect male fertility.
Danish: • Behandling med Silodyx kan føre til unormal ejakulation (reduktion i mængden af sæd, der frigives under samleje), hvilket midlertidigt kan påvirke den mandlige frugtbarhed.
English: Since only limited experience exists in patients with moderate renal impairment (n = 35), a lower starting dose of 4 mg is recommended.
Danish: Da der kun er begrænset erfaring med patienter med moderat nedsat nyrefunktion (n = 35), anbefales en lavere startdosis på 4 mg. Silodyx bør ikke anvendes til patienter med svært nedsat nyrefunktion.
English: Other medicines and Silodyx
Danish: Brug af anden medicin sammen med Silodyx
English: If you stop taking Silodyx
Danish: Hvis De holder op med at tage Silodyx
English: Titanium dioxide (E171) Yellow iron oxide (E172) (4 mg capsules only)
Danish: Gul jernoxid (E172) (kun 4 mg kapsel)
English: The recommended dose is one capsule of Silodyx 8 mg daily.
Danish: Den anbefalede dosis er én kapsel Silodyx 8 mg dagligt.
English: Silodyx 8 mg are white, opaque, hard gelatin capsules, size 0 (approximately 21.7 x 7.6 mm).
Danish: Silodyx 8 mg er hvide, uigennemsigtige, hårde gelatinekapsler, størrelse 0 (cirka 21,7 x 7,6 mm).
English: Yellow, opaque, hard gelatin capsule, size 3 (approximately 15.9 x 5.8 mm).
Danish: Gul, uigennemsigtig, hård gelatinekapsel, størrelse 3 (cirka 15,9 x 5,8 mm).
English: Urorec may reduce the amount of sperm, and so could temporarily affect your ability to father a child.
Danish: Silodyx kan nedsætte mængden af sædceller og dermed midlertidigt påvirke Deres evne til at gøre en kvinde gravid.
English: Urticaria1 Drug eruption1
Danish: Medikamentel eruption1
English: Silodyx is selective for the receptors located in the prostate, bladder and urethra.
Danish: Silodyx påvirker nogle receptorer, som findes i blærehalskirtlen, blæren og urinrøret.
English: 2D barcode carrying the unique identifier included.
Danish: 17 ENTYDIG IDENTIFIKATOR - 2D-STREGKODE Der er anført en 2D-stregkode, som indeholder en entydig identifikator
English: White, opaque, hard gelatin capsule, size 0 (approximately 21.7 x 7.6 mm).
Danish: Hvid, uigennemsigtig, hård gelatinekapsel, størrelse 0 (cirka 21,7 x 7,6 mm).
English: For this purpose Silodyx 4 mg hard capsules are available.
Danish: Til dette formål findes Silodyx 4 mg hårde kapsler.
English: Allergic-type reactions including facial swelling, swollen tongue and pharyngeal oedema1
Danish: Allergilignende reaktioner herunder hævelse af ansigt og tunge og faryngealt ødem1
English: Takeda Italia S.p.A. Tel: +39 06 502601
Danish: Tel: + 39 06 502601
English: Tachycardia1 Palpitations1
Danish: Palpitationer1
English: Very common side effects (may affect more than 1 in 10 people)
Danish: Meget almindelige bivirkninger(kan forekomme hos flere end 1 ud af 10 personer)
English: The recommended dose is one capsule of Silodyx 8 mg per day by oral administration.
Danish: Den anbefalede dosis er en kapsel Silodyx 8 mg pr. dag givet oralt (gennem munden).
English: A starting dose of 4 mg once daily is recommended in patients with moderate renal impairment (CLCR ≥ 30 to < 50 mL/min), which may be increased to 8 mg once daily after one week of treatment, depending on the individual patient's response.
Danish: Denne dosis kan forøges til 8 mg én gang dagligt efter en uges behandling, afhængig af den enkelte patients respons.
English: Almirall, S.A. Tel: +34 93 291 30 00
Danish: Tel: +34 93 291 30 00
English: Silodyx 4 mg hard capsules Each hard capsule contains 4 mg silodosin.
Danish: Silodyx 4 mg hårde kapsler Hver hård kapsel indeholder 4 mg silodosin.
English: Silodyx 8 mg hard capsules Each hard capsule contains 8 mg silodosin.
Danish: Silodyx 8 mg hårde kapsler Hver hård kapsel indeholder 8 mg silodosin.
English: EU/1/09/607/001 EU/1/09/607/002 EU/1/09/607/003 EU/1/09/607/004 EU/1/09/607/005 EU/1/09/607/006 EU/1/09/607/007 EU/1/09/607/008 EU/1/09/607/009 EU/1/09/607/010 EU/1/09/607/011 EU/1/09/607/012 EU/1/09/607/013 EU/1/09/607/014
Danish: EU/1/09/607/001 EU/1/09/607/002 EU/1/09/607/003 EU/1/09/607/004 EU/1/09/607/005 EU/1/09/607/006 EU/1/09/607/007 EU/1/09/607/008 EU/1/09/607/009 EU/1/09/607/010
English: How to take Silodyx
Danish: Sådan skal De tage Silodyx
English: Capsule shell
Danish: Kapselindhold
English: What Silodyx is and what it is used for What you need to know before you take Silodyx How to take Silodyx
Danish: Det skal De vide, før De begynder at tage Silodyx Sådan skal De tage Silodyx Bivirkninger
English: Silodyx 8 mg hard capsules
Danish: Silodyx 8 mg hårde kapsler
English: Silodyx 4 mg hard capsules
Danish: Silodyx 4 mg hårde kapsler
English: Zambon Nederland B.V. Tel: + 31 33 4504370
Danish: Tel: + 31 33 4504370
English: The use of silodosin in patients with severe renal impairment (CLCR <30 ml/min) is not recommended (see sections 4.2 and 5.2).
Danish: Silodosin bør ikke anvendes til patienter med svært nedsat nyrefunktion (CLCR < 30 ml/min) (se pkt.
English: Silodyx is available in packs containing 5, 10, 20, 30, 50, 90, 100 capsules.
Danish: Silodyx 4 mg er gule, uigennemsigtige, hårde gelatinekapsler, størrelse 3 (cirka 15,9 x 5,8 mm).. Silodyx findes i pakningsstørrelser med 5, 10, 20, 30, 50, 90 og 100 kapsler.
English: Silodyx 4 mg hard capsules Silodyx 8 mg hard capsules
Danish: LÆGEMIDLETS NAVN Silodyx 4 mg hårde kapsler Silodyx 8 mg hårde kapsler
English: Body clearance of silodosin was approximately 0.28 L/h/kg.
Danish: 0,28 l/h/kg.
English: Silodyx 4 mg hard capsules silodosin
Danish: LÆGEMIDLETS NAVN Silodyx 4 mg hårde kapsler silodosin
English: Silodyx 8 mg hard capsules silodosin
Danish: LÆGEMIDLETS NAVN Silodyx 8 mg hårde kapsler silodosin
English: What Silodyx is used for
Danish: Silodyx indeholder
English: 10 April 2013
Danish: Den 10. april 2013
English: The European Commission issued a decision on 10 April 2013.
Danish: Europa-Kommissionen traf en afgørelse den 10. april 2013.
English: In December 2011, the company applied for an additional use in Germany.
Danish: I december 2011 ansøgte virksomheden om en ekstra anvendelse i Tyskland.
English: The Committee looked at the study presented by the company to support its application.
Danish: Udvalget gennemgik den undersøgelse, som virksomheden havde forelagt til støtte for ansøgningen.
English: Outcome of a procedure under Article 13 of Regulation (EC) 1234/2008
Danish: Resultatet af en procedure i henhold til artikel 13 i forordning (EF) nr.
English: What is Kantos Master?
Danish: Hvad er Kantos Master?
English: The company that makes the medicine is Chiesi.
Danish: Den virksomhed, der fremstiller lægemidlet, er Chiesi.
English: It is inhaled once or twice a day, in order to keep asthma under control and reduce symptoms.
Danish: Det inhaleres en eller to gange dagligt for at holde astmaen under kontrol og mindske symptomerne.
English: On 17 January 2013, the European Medicines Agency completed an arbitration procedure for Kantos Master and associated names.
Danish: Den 17. januar 2013 gennemførte Det Europæiske Lægemiddelagentur en voldgiftsprocedure for Kantos Master og relaterede navne.
English: Why was Kantos Master reviewed?
Danish: Hvorfor blev Kantos Master vurderet igen?
English: On 13 December 2012, Germany referred the matter to the CHMP for arbitration.
Danish: Den 13. december 2012 indbragte Tyskland sagen for CHMP til voldgift.
English: Kantos Master is authorised under a mutual recognition procedure based on an initial authorisation granted by Germany.
Danish: Kantos Master er godkendt ved en gensidig anerkendelsesprocedure, der er baseret på den oprindelige godkendelse i Tyskland.
English: Kantos Master is used as maintenance therapy in patients who have asthma.
Danish: Kantos Master anvendes som vedligeholdelsesbehandling hos patienter med astma.
English: However, the Member States were unable to reach agreement on whether to accept this indication for Kantos Master.
Danish: Medlemsstaterne var imidlertid ude af stand til at nå til enighed om godkendelse af denne anvendelse af Kantos Master.
English: Kantos Master is marketed in all EU Member States except Czech Republic, Ireland, Malta Portugal and Slovakia under the names Kantos, Formodual, Foster, Inuxair, Innovair and associated names.
Danish: Kantos Master markedsføres i alle EU medlemsstater undtagen Irland, Malta, Portugal, Slovakiet og Tjekkiet under navnene Kantos, Formodual, Foster, Inuxair, Innovair og relaterede navne.
English: The CHMP therefore concluded that the benefits of Kantos Master for MART outweigh its risks and recommended that the marketing authorisation be granted in Germany and the concerned Member States.
Danish: CHMP konkluderede derfor, at fordelene ved Kantos Master til vedligeholdelses- og behovsbehandling opvejer risiciene, og anbefalede udstedelse af markedsføringstilladelse i Tyskland og de berørte medlemsstater.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) had been asked to arbitrate on a requested change to the marketing authorisation for these medicines to include a new use as rescue therapy for acute relief of asthma symptoms.
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) var blevet anmodet at være voldgiftsinstans vedrørende en ændringsansøgning for disse lægemidler med henblik på tilføjelse af en ny anvendelse, nemlig redningsbehandling til akut lindring af astmasymptomer.
English: Kantos Master is a medicine that contains two active substances: beclomethasone dipropionate, a corticosteroid (a medicine that reduces inflammation), and formoterol fumarate, a bronchodilator (a medicine that opens the airways, allowing easier breathing) with a long duration of action.
Danish: Kantos Master er et lægemiddel, der indeholder to aktive stoffer, nemlig beclometasondipropionat, som er et binyrebarkhormon (et lægemiddel, der mindsker inflammation), og formoterolfumarat, der er en langtidsvirkende bronkodilator (et lægemiddel, der åbner luftvejene, så vejrtrækningen lettes).
English: Questions and answers on Kantos Master and associated names (beclomethasone dipropionate / formoterol fumarate, inhaler) EMA/21628/2013 rev.1
Danish: Spørgsmål og svar om Kantos Master og relaterede navne (beclometasondipropionat/formoterolfumarat, inhalator) EMA/21628/2013 rev.1
English: Based on the evaluation of the currently available data and the scientific discussion within the Committee, the CHMP agreed that Kantos Master has been shown to reduce the risk of severe exacerbation of asthma and prolong the time between exacerbations when part of the dose is given on an as-needed basis as MART.
Danish: Efter vurdering af de foreliggende data og den videnskabelige drøftelse i udvalget fandt CHMP det bevist, at Kantos Master mindsker risikoen for episoder med svær forværring af astma, og at der går længere tid mellem forværringsepisoderne, når en del af dosis gives efter behov som led i en vedligeholdelses- og behovsbehandling.
English: The Committee concluded that the benefits of Kantos Master outweigh its risks in the new use and the change to the marketing authorisation can be granted in Germany and the following Member States: Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Greece, Hungary, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Poland, Romania, Slovenia, Spain, Sweden and the United Kingdom.
Danish: Udvalget konkluderede, at fordelene ved Kantos Master opvejer risiciene til den nye anvendelse, og anbefalede udstedelse af en ændret markedsføringstilladelse i Tyskland og følgende medlemsstater: Belgien, Bulgarien, Cypern, Danmark, Det Forenede Kongerige, Estland, Finland, Frankrig, Grækenland, Italien, Letland, Litauen, Luxembourg, Nederlandene, Norge, Polen, Rumænien, Slovenien, Spanien, Sverige, Ungarn og Østrig.
English: Questions and answers on Kantos Master and associated names (beclomethasone dipropionate / formoterol fumarate, inhaler)
Danish: Spørgsmål og svar om Kantos Master og relaterede navne (beclometasondipropionat/formoterolfumarat, inhalator)
English: It also took note of relevant literature supporting the principle of using such a combination of corticosteroid and long-acting bronchodilator (beclometasone and formoterol) for MART.
Danish: Udvalget tog desuden hensyn til relevant litteratur, der støtter princippet om vedligeholdelses- og behovsbehandling med en sådan kombination af binyrebarkhormon og langtidsvirkende bronkodilator (beclometason og formoterol).
English: If patients develop symptoms of asthma (wheezing and difficulty breathing) inhalation of a separate bronchodilator medicine with a rapid onset and short duration of action is advised for relief (rescue therapy).
Danish: Hvis patienten får astmasymptomer (hvæsende, besværlig vejrtrækning) tilrådes det at inhalere en separat bronkodilator med hurtigt indsættende, kortvarig virkning for at lette symptomerne (redningsbehandling).
English: Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom (the ‘concerned Member States').
Danish: Danmark, Det Forenede Kongerige, Estland, Finland, Frankrig, Grækenland, Italien, Letland, Litauen, Luxembourg, Nederlandene, Norge, Polen, Portugal, Rumænien, Slovakiet, Slovenien, Spanien, Sverige, Ungarn og Østrig ("de berørte medlemsstater").
English: The grounds for the referral were the concerns of Sweden that the data on Kantos Master submitted in the application were not sufficient to demonstrate its effectiveness for MART.
Danish: Begrundelsen for indbringelsen var Sveriges betænkelighed ved, at oplysningerne i ansøgningen om Kantos Master ikke var tilstrækkelige som dokumentation af lægemidlets effektivitet til vedligeholdelses- og behovsbehandling.
English: The CHMP noted that MART was not compared with the standard of care according to current guidelines, but agreed that there was no evidence that patients in the comparison group had been undertreated, as patients in both groups had shown clinical benefit from their maintenance treatment.
Danish: Udvalget fandt dog ikke tegn på, at patienterne i sammenligningsgruppen var blevet underbehandlet, da patienterne i begge grupper havde haft klinisk fordel af vedligeholdelsesbehandlingen.
English: The application was for the use of Kantos Master for both maintenance therapy of asthma and for relief of symptoms when they arise instead of the use of a separate short-acting bronchodilator (maintenance and reliever therapy, or MART).
Danish: Ansøgningen vedrørte anvendelse af Kantos Master både til vedligeholdelsesbehandling af astma og til lindring af symptomer, når de opstår (vedligeholdelses- og behovsbehandling), i stedet for anvendelse af en separat kortvirkende bronkodilator.
English: The company wanted the authorisation to be recognised in the following Member States: Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Greece, Hungary, Italy, Latvia, Lithuania,
Danish: Virksomheden ønskede godkendelsen anerkendt i følgende medlemsstater: Belgien, Bulgarien, Cypern,
English: In particular, in the main study comparing the use of Kantos Master for MART versus maintenance treatment with Kantos Master plus a short-acting bronchodilator given for relief, there were concerns that the comparison group might not have been receiving adequate maintenance treatment, which could have made the results in the MART group look better than they really were.
Danish: Navnlig var der betænkelighed ved hovedundersøgelsen, hvor Kantos Master som vedligeholdelses- og behovsbehandling blev sammenlignet med vedligeholdelsesbehandling med Kantos Master plus en kortvirkende bronkodilator til afhjælpning af symptomer.
English: This four-week period is one ‘cycle'.
Danish: Denne periode på fire uger er én "cyklus".
English: Vidaza azacitidine
Danish: Vidaza azacitidin
English: The main measure of effectiveness was how long the patients survived.
Danish: Det primære effektmål var, hvor længe patienterne overlevede.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Vidaza on 17 December 2008.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Vidaza den 17. december 2008.
English: Treatment continues for at least six cycles and then for as long as it benefits the patient.
Danish: Behandlingen fortsættes i mindst seks cyklusser, og derefter så længe patienten har gavn af den.
English: The effect of Vidaza was similar in all three diseases.
Danish: Effekten af Vidaza var omtrent den samme ved alle tre sygdomme.
English: The liver, kidneys and blood should be checked before each cycle.
Danish: Lever, nyrer og blod skal undersøges inden hver cyklus.
English: This is a summary of the European public assessment report (EPAR) for Vidaza.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Vidaza.
English: Vidaza has been studied in two main studies.
Danish: Vidaza har været genstand for to hovedundersøgelser.
English: The full EPAR for Vidaza can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Vidaza findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: What measures are being taken to ensure the safe and effective use of Vidaza?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Vidaza?
English: If the blood counts fall too low or if the patient develops kidney problems, the next treatment cycle should be delayed or a lower dose should be used.
Danish: Hvis blodtallene falder for meget, eller hvis patienten udvikler nyreproblemer, bør den næste cyklus udsættes, eller der bør anvendes en mindre dosis.
English: Other information about Vidaza
Danish: Andre oplysninger om Vidaza